ProfessionalNo New Dates

Ketamine in Psychotherapy: Opportunities to Explore by Will Van Derveer, MD

This course discusses ketamine in psychotherapy through the lens of integrative psychiatry and treatment-resistant depression. It focuses on the default mode network, depression, and how ketamine may create an opening for change alongside broader therapeutic support.

Provider

IPI

English

Schedule

10 days

Enrollment

Price on request

Course Overview

This course explores how integrative psychiatry approaches common conditions such as treatment-resistant depression and frames depression as a multifactorial condition linked to missing resources for health. It presents the default mode network as a key concept for understanding habitual thought patterns, negativity bias, and the limits of talk therapy alone in shifting deeper patterns. The session also reviews how meditation research relates to default mode network activity and how ketamine has been studied for its effects on connectivity involving the insula and the default mode network. The discussion emphasizes that ketamine may create an opportunity for change, but is not presented as a standalone root-cause solution. The content is suited to learners interested in psychotherapy, integrative psychiatry, and the neurobiology of depression. Practical takeaways include supporting broader recovery through journaling, exercise, diet changes, and relationship work alongside clinical treatment.

Who is this for?

Learners interested in psychotherapy, integrative psychiatry, and the neurobiology of depression.

About the Provider

Educational platform co-founded by Dr. Will Van Derveer and Keith Kurlander that trains therapists, physicians, and nurses in psychedelic-assisted therapy through a year-long online program taught by 50+ experts including Robin Carhart-Harris, Michael Pollan, and Rick Doblin. IPI's curriculum covers evidence-based protocols for PTSD, depression, and anxiety, and partners with the Usona Institute and MAPS to prepare clinicians for emerging MDMA- and psilocybin-assisted treatments.

Related Courses

View all courses